Mindray Medical International Ltd (ADR)  

(Public, NYSE:MR)   Watch this stock  
Find more results for MR
32.13
0.00 (0.00%)
Apr 22 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range     -
52 week 30.03 - 43.81
Open     -
Vol / Avg. 0.00/850,782.00
Mkt cap 3.77B
P/E 17.18
Div/yield 0.50/1.56
EPS 1.87
Shares 117.43M
Beta 1.17
Inst. own 98%
May 6, 2014
Q1 2014 Mindray Medical International Limited Earnings Conference Call - 8:00AM EDT - Add to calendar
May 5, 2014
Q1 2014 Mindray Medical International Limited Earnings Release - 4:00PM EDT - Add to calendar
Mar 4, 2014
Q4 2013 Mindray Medical International Limited Earnings Conference Call - Webcast
Mar 3, 2014
Q4 2013 Mindray Medical International Limited Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '13) 2013
Net profit margin 20.94% 18.99%
Operating margin 14.65% 17.32%
EBITD margin - 21.76%
Return on average assets 12.99% 10.57%
Return on average equity 20.20% 15.77%
Employees 7,860 -
CDP Score - -

Address

Mindray Building Keji 12th Road South, Hi-tech Ind. Park Nanshan
SHENZHEN, GNG 518057
China
+86-755-81888666 (Phone)
+86-755-26582680 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Mindray Medical International Limited (Mindray International), is a developer, manufacturer and marketer of medical devices worldwide. The Company operates in three segments: patient monitoring and life support products, in-vitro diagnostic products and medical imaging systems. The Company provides after-sales services to distributors and hospitals in China through 32 local offices based in provincial capital cities. It also provides after-sales services to hospitals in the United States, the United Kingdom, France and Germany. In addition, the Company provides after-sales service to its international customers through its distribution channel where it does not engage in direct sales activities. In July 2013, Mindray Medical International Ltd completed the acquisition of ZONARE Medical Systems, Inc.

Officers and directors

Hang Xu Chairman of the Board
Age: 50
Bio & Compensation  - Reuters
Xiting Li President, Co-Chief Executive Officer, Director
Age: 61
Bio & Compensation  - Reuters
Minghe Cheng Co-Chief Executive Officer, Chief Strategic Officer
Age: 51
Bio & Compensation  - Reuters
Alex Lung Chief Financial Officer
Age: 41
Bio & Compensation  - Reuters
Jie Liu Chief Operating Officer
Age: 44
Bio & Compensation  - Reuters
Jianxin Wang Chief Administrative Officer
Bio & Compensation  - Reuters
May Li Chief Investment Officer
Bio & Compensation  - Reuters
Fannie Lin Fan Group General Counsel, Secretary of Board of Directors
Age: 40
Bio & Compensation  - Reuters
Ronald H. Ede Director
Age: 54
Bio & Compensation  - Reuters
Qiyao Wu Director
Age: 76
Bio & Compensation  - Reuters